OTC ACTUAL-USE STUDIES ON PROPOSED LABELING
This article was originally published in The Tan Sheet
Executive Summary
OTC ACTUAL-USE STUDIES ON PROPOSED LABELING are essential to FDA because they "can provide actual data evaluating actual labels or label design variations," Louis Morris, PhD, of FDA's Division of Drug Marketing, Advertising and Communications, told a Sept. 9 meeting of a subcommittee of FDA's Nonprescription Drugs and Arthritis Advisory Committees.